Search Results

Alternate Access Approaches for Self-Expanding TAVR Devices

Developing transcatheter aortic valve replacement technology will allow treatment for a broader spectrum of patient anatomies.

By Nicolas M. Van Mieghem, MD; Carl Schultz, MD, PhD; Hafid Amrane, MD; and Peter P. de Jaegere, MD, PhD

Aortic Valve Update

By Ted E. Feldman, MD, FSCAI, Chief Medical Editor

TAVI Using the CoreValve Revalving System

An update on device data and the latest trial findings.

By Jeffery J. Popma, MD; Roger Laham, MD; Robert Hagberg, MD; and Kamal Khabbaz, MD

Managing Right Ventricular Failure in Pulmonary Embolism

Experience and evidence for the use of mechanical circulatory support for managing high-risk PE associated with shock.

By Megan Burke, MD, and Sameer J. Khandhar, MD

Contemporary Trends in Diagnosis and Management of Pulmonary Embolism

A review of the identification and classification of acute pulmonary embolic disease and modern management strategies.

By Daniel Heikali, MD, and Suhail Dohad, MD

Precision PCI: Making the Complex Simple or the Simple Complex?

Evaluating OCT imaging guidance in everyday practice as a new standard of care.

By Evan Shlofmitz, DO, and Richard Shlofmitz, MD

Hemodynamic Collapse in the Cardiac Catheterization Laboratory: Prevent, Prepare, Manage, and Recover

Successful management of hemodynamic collapse in the cardiac catheterization laboratory relies on advance preparation, prevention, anticipation, awareness, and teamwork.

By Alexander G. Truesdell, MD; Ilan Vavilin, MD; Jonathan Boeddiker, RT(R), NRP, FP-C; Brittany Steinmetz, RT(R), RCIS; Megan Terek, MD; and Eric Rothstein, MD

Do the New DAPT Guidelines Result in Any Real Changes in Practice?

With John A. Bittl, MD; Robert Yeh, MD, MSc, MBA; Eric A. Secemsky, MD, MSc; Eric R. Bates, MD; and Issam D. Moussa, MD, FACC, FAHA, FSCAI

Selection of Hemodynamic Support: An Approach for Coronary Interventions in Shock and High-Risk PCI

The role of hemodynamic support devices in emergent cardiogenic shock and elective high-risk percutaneous coronary intervention.

By Sahil Khera, MD, MPH, and Srihari S. Naidu, MD